Contract award · W81XWH22C0096
AWARD OF CHROMOLOGIC'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "RADIOPROTECTION BY JP4-039-MLV NANOPARTICLE DRUGS"
Awarded to CHROMOLOGIC LLC · CAGE 474C3
Latest reported total obligated
Not reported
Net observed obligations
$1.1M
Observed contract actions
2
Observed period
FY2022–FY2024
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorCHROMOLOGIC LLC
CAGE474C3
CustomerDepartment of the Army
Performance locationMONROVIA, CALIFORNIA, UNITED STATES
Procurement details
First observed actionAug 22, 2022
Latest observed actionMar 14, 2024
PSCAN11
NAICS541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CompetitionFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
PricingFIRM FIXED PRICE
SolicitationHQ003420R1CDB
Annual observed obligations
FY2022
$1.1M
Continue exploring
Ask Mimir about W81XWH22C0096
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.